FDA Authorizes Pfizer Boosters for Kids 5 to 11

It's true. Research has shown there is no benefit of a COVID shot for this age group, and the chance of death from the shot is actually 107 times higher than death from COVID.

STORY AT-A-GLANCE

• The FDA has authorized the use of a booster COVID-19 shot in children ages 5 to 11; less than one-third — only 28.8% — of U.S. children in this age group have received the first two doses of this experimental gene therapy

• Effectiveness of COVID-19 shots in children wanes rapidly; a CDC study found that two to four weeks after the second …